← Who reports today · Health Care
How UnitedHealth Group (UNH) makes money: Q3 2026 revenue breakdown
Net earnings attributable to UnitedHealth Group common shareholders
$4,110M
up 75.0% y/y
Total revenues
$112,694M
down 0.4% y/y
Earnings from operations
$6,563M
up 52.1% y/y
Next report
~ Jan 26
not announced yet
The quarter in brief
Revenue slipped 0.4% y/y to $112.7 billion, but earnings from operations rose 52.1% to $6.6 billion. Net earnings attributable to shareholders grew 75.0% to $4,110 million and diluted EPS rose to $4.56 from $2.59.
Key growth driver: Products — the fastest-growing revenue line: $14,293, +8% y/y. · by the Q3 2026 report
How does UnitedHealth Group make money?
UnitedHealth Group brought in $113 billion of revenue in Q3 2026, down 0.4% year over year. The largest source was Premiums: $87.1 billion, or 77% of the total, followed by Products ($14.3B, 13%) and Services ($10.2B, 9%); other lines add the remaining 1%. Net income for the quarter was $4.11 billion, up 75.0% year over year.
Revenue by source, Q3 2026
- Premiums$87.1B · 77% · −2.1%
- Products$14.3B · 13% · +7.5%
- Services$10.2B · 9% · +5.0%
- Investment and other income$1.08B · 1% · −4.9%
Shares of $113B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.
All figures in $M.
| Line item | Amount and change |
|---|---|
| Premiums | $87,078 · −2.1% |
| Products | $14,293 · +7.5% |
| Services | $10,246 · +5.0% |
| Investment and other income | $1,077 · −4.9% |
| Total revenues | $112,694 · −0.4% |
| Medical costs | $76,982 · −3.7% |
| Cost of products sold | $13,707 · +9.1% |
| Operating costs | $14,369 · −5.6% |
| Depreciation and amortization | $1,073 · −2.4% |
| Earnings from operations | $6,563 · +52.1% · 5.8% margin |
| Interest expense | $963 · −4.0% |
| Loss on sale of subsidiary and subsidiaries held for sale | $76 · −8.4% |
| Earnings before income taxes | $5,524 · +71.1% |
| Provision for income taxes | $1,224 · +78.4% · 22.2% effective rate |
| Earnings attributable to noncontrolling interests | $190 · −2.6% |
| Net earnings attributable to UnitedHealth Group common shareholders | $4,110 · +75.0% · $4.56/sh · 3.6% margin |
Verdict: revenue slipped 0.4% y/y to $112.7 billion, but earnings from operations rose 52.1% to $6.6 billion. Net earnings attributable to shareholders grew 75.0% to $4,110 million and diluted EPS rose to $4.56 from $2.59.
The company raised its full year 2026 outlook to at least $19.50 per share of GAAP earnings and at least $20.50 of adjusted earnings per share. Year-to-date it repurchased $5.0 billion of common stock and paid $6.2 billion in dividends.
Source and notation
Source: UnitedHealth Group press release, 8-K EX-99.1 of 10/13/2026 (SEC EDGAR).
Open as an image: UnitedHealth Group (UNH), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “UnitedHealth Group (UNH) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/unh. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/unh"><img src="https://whoreportstoday.com/t/unh/img/unitedhealth-group-unh-earnings-sankey.png" alt="UnitedHealth Group (UNH) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/unh">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/unh/img/unitedhealth-group-unh-earnings-sankey.png
<a href="https://whoreportstoday.com/t/unh">UnitedHealth Group (UNH) Q3 2026 earnings chart (Who Reports Today)</a>
The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Medical costs fell 3.7% y/y to $76,982 million while premiums declined to $87,078 million from $88,979 million, and the quarter included $610 million of net favorable prior period reserve development.
- The operating cost ratio improved to 12.8% from 13.5%, with operating costs down to $14,369 million from $15,223 million.
- Operating margin widened to 5.8% from 3.8%; UnitedHealthcare earnings from operations rose to $2,831 million from $1,805 million and Optum to $3,732 million from $2,510 million.
- Optum Health earnings from operations rose to $735 million from $41 million, even as its revenue fell 10% to $22.9 billion.
- Interest expense declined to $963 million from $1,003 million, and losses on South American subsidiaries held for sale were $76 million.
- The effective tax rate rose to 22.2% from 21.2%.
- Diluted shares fell to 902 million from 908 million; adjusted EPS was $4.69 versus $2.92.
What distorts the picture in this report and what to watch beyond the headlines.
Who runs the company now
As of 11/18/2026, per the company’s SEC filings: signatures on the latest report and leadership-change filings.
Positions and previous jobs: the company’s SEC filings. Spotted an error, or is this you and you’d like it corrected or removed? Contact us
Where they worked before
- UnitedHealth Groupsince 1998
- Chief Executive Officer and Chair of the Boardsince 2025
- Directorsince 2000
- Non-Executive Chair of the Board2019–2025
- Executive Chair of the Board2017–2019
- Chief Executive Officer2006–2017
- President1999–2014
- Chief Operating Officer1998–2006
Source: SEC EDGAR: 10-K annual report, 2026-03-02 · as of 10/21/2026
- UnitedHealth Groupsince 2025Chief Financial Officer
- Bain Capital2022–2025Managing Director
- Surgery Partners2018–2025
- Executive Chairman of the Board2020–2025
- Chief Executive Officer2018–2020
- Elevance Health2007–2016Executive Vice President and Chief Financial Officer
Source: SEC EDGAR: 10-K annual report, 2026-03-02 · as of 10/21/2026
How this is compiled
Who runs the company now comes from primary sources only: for US and Canadian companies, the CEO and CFO signatures on the latest SEC report, and a separate board chair from the proxy materials; for Russian and Kazakh issuers, the company website and its disclosures. We recheck weekly; if a name can’t be confirmed, or a leadership-change filing came out after the report, we don’t show it until it’s reviewed. Previous jobs are only what the company itself disclosed about its current leaders (the past five years of business experience in the annual report and proxy materials): employer, position and years, restated as facts, with no age, education or other personal details. If the company doesn’t disclose it, we don’t look elsewhere. Anything more than 400 days past its last check is hidden. These are public business facts from disclosures, shown to tell investors who runs the company (our legitimate interest); if this is you and you object, contact us via the link above and we’ll remove it.
Sources · 1
- SEC EDGAR: 10-Q 2026-11-03 · SEC EDGAR · 11/18/2026
UnitedHealth Group Incorporated is an American multinational company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. · Text: Wikipedia, CC BY-SA 4.0, abridged
Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.
Company reports
Company guidance
The company reaffirmed its outlook, no figures in the release.
Same quarter a year ago (ended December 31, 2025): revenue $113.2B, EPS (GAAP) $0.05
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
Guidance comes from the company's earnings release (Form 8-K filed Oct 13, 2026); every figure is checked against the release text.
UNH earnings history: past report dates
| Jul 16, 2026 Thu | 6:00 ambefore market open | Jun 30, 2026 | $112B+0% y/y | $6.04+61% y/y |
| Apr 21, 2026 Tue | 6:02 ambefore market open | Mar 31, 2026 | $112B+2% y/y | $6.90+1% y/y |
| Jan 27, 2026 Tue | 6:02 ambefore market open | Dec 31, 2025 | ≈$113B+12% y/y | ≈$0.05−99% y/y |
| Oct 28, 2025 Tue | 6:02 ambefore market open | Sep 30, 2025 | $113B+12% y/y | $2.59−60% y/y |
| Jul 29, 2025 Tue | 6:04 ambefore market open | Jun 30, 2025 | $112B+13% y/y | $3.74−18% y/y |
| Apr 17, 2025 Thu | 6:01 ambefore market open | Mar 31, 2025 | $110B+10% y/y | $6.85 |
| Jan 16, 2025 Thu | 6:02 ambefore market open | Dec 31, 2024 | ≈$101B+7% y/y | ≈$5.99+2% y/y |
| Oct 15, 2024 Tue | 6:03 ambefore market open | Sep 30, 2024 | $101B+9% y/y | $6.51+4% y/y |
| Jul 16, 2024 Tue | 6:01 ambefore market open | Jun 30, 2024 | $98.9B+6% y/y | $4.54−22% y/y |
| Apr 16, 2024 Tue | 6:01 ambefore market open | Mar 31, 2024 | $99.8B+9% y/y | −$1.53 |
| Jan 12, 2024 Fri | 6:01 ambefore market open | Dec 31, 2023 | ≈$94.4B+14% y/y | ≈$5.85+16% y/y |
| Oct 13, 2023 Fri | 6:03 ambefore market open | Sep 30, 2023 | $92.4B+14% y/y | $6.24+12% y/y |
| Jul 14, 2023 Fri | 6:04 ambefore market open | Jun 30, 2023 | $92.9B+16% y/y | $5.82+9% y/y |
| Apr 14, 2023 Fri | 6:02 ambefore market open | Mar 31, 2023 | $91.9B+15% y/y | $5.95+13% y/y |
| Jan 13, 2023 Fri | 6:01 ambefore market open | Dec 31, 2022 | ≈$82.8B+12% y/y | ≈$5.03+18% y/y |
Show all 15 reports since 2023Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
UnitedHealth Group: 15-year financials
| 2025 | 447,567 | 18,964 | 12,056 | 16,075 | 7,916 |
| 2024 | 400,278 | 32,287 | 14,405 | 20,705 | 7,533 |
| 2023 | 371,622 | 32,358 | 22,381 | 25,682 | 6,761 |
| 2022 | 324,162 | 28,435 | 20,120 | 23,404 | 5,991 |
| 2021 | 287,597 | 23,970 | 17,285 | 19,889 | 5,280 |
| 2020 | 257,141 | 22,405 | 15,403 | 20,123 | 4,584 |
| 2019 | 242,155 | 19,685 | 13,839 | 16,392 | 3,932 |
| 2018 | 226,247 | 17,344 | 11,986 | 13,650 | 3,320 |
| 2017 | 201,159 | 15,209 | 10,558 | 11,573 | 2,773 |
| 2016 | 184,840 | 12,930 | 7,017 | 8,090 | 2,261 |
| 2015 | 157,107 | 11,021 | 5,813 | 8,184 | 1,786 |
| 2014 | 130,474 | 10,274 | 5,619 | 6,526 | 1,362 |
| 2013 | 122,489 | 9,623 | 5,625 | 5,684 | 1,056 |
| 2012 | 110,618 | 9,254 | 5,526 | 6,085 | 820 |
| 2011 | 101,862 | 8,464 | 5,142 | 5,901 | 651 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
* Sources
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. Dividends paid and share buybacks are actual annual cash payments from the cash flow statement, shown as positive cash outflows. Payments to noncontrolling interests and share-compensation withholding taxes are excluded. New values require three checks against issuer documents; unreviewed data is a dash and confirmed absence of payment is 0. Buybacks appear only when at least one reviewed payment exists in fifteen years. Updated after annual filings and document review. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
UnitedHealth Group: 15-year balance sheet
| Year | Assets | Equity | Debt | Cash | Current assets | Current liabilities |
|---|---|---|---|---|---|---|
| 2025 | 309,581 | 100,090 | 77,681 | 24,365 | 90,582 | 114,897 |
| 2024 | 298,278 | 98,268 | 76,180 | 25,312 | 85,779 | 103,769 |
| 2023 | 273,720 | 94,421 | 61,473 | 25,427 | 78,437 | 99,054 |
| 2022 | 245,705 | 81,450 | 56,756 | 23,365 | 69,069 | 89,237 |
| 2021 | 212,206 | 75,045 | 44,632 | 21,375 | 61,758 | 78,292 |
| 2020 | 197,289 | 68,328 | 42,280 | 16,921 | 53,718 | 72,420 |
| 2019 | 173,889 | 60,436 | 39,474 | 10,985 | 42,634 | 61,782 |
| 2018 | 152,221 | 54,319 | 35,234 | 10,866 | 38,692 | 53,209 |
| 2017 | 139,058 | 49,833 | 31,067 | 11,981 | 37,084 | 50,463 |
| 2016 | 122,810 | 38,177 | 32,770 | 10,430 | 33,879 | 49,252 |
| 2015 | 111,254 | 33,725 | 31,801 | 10,923 | 31,639 | 42,898 |
| 2014 | 86,300 | 32,454 | 17,256 | 7,495 | 23,556 | 30,623 |
| 2013 | 81,882 | 32,149 | 16,860 | 7,276 | 20,380 | 27,881 |
| 2012 | 80,885 | 31,178 | 16,754 | 8,406 | 21,052 | 27,116 |
| 2011 | 67,889 | 28,292 | 11,638 | 9,429 | 20,350 | 23,922 |
$ millions, at fiscal year-end*.
* Sources
How we calculate
Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .
Cash flow, 1 year
| Year | CFO · Operating cash flow | CAPEX · Capital expenditure | FCF · Free cash flowcalculated | Dividends paid | CFI · Investing cash flow | CFF · Financing cash flow |
|---|---|---|---|---|---|---|
| 20112011-12-31 | — | — | — | 651 | — | — |
More detailsHide details
Bank or insurer: CAPEX and FCF do not apply to this business model — “—”.
$ millions, per fiscal year; ratios in %. “—” — no verified data or calculation not applicable.
* Sources
How we calculate
CFO, CFI and CFF are net operating, investing and financing cash flows. CAPEX is a positive cash outflow for capital expenditure; its scope follows the issuer document line. FCF = CFO − CAPEX; lease repayments are not deducted separately. If no separately sourced numeric CAPEX amount is available, CAPEX and FCF calculations are omitted. FCF margin = FCF / same-year revenue × 100. FCF / net income = FCF / same-year income attributable to shareholders × 100; losses or zero income produce a dash. Revenue and income use this card’s indicators table; missing or mismatched periods produce no ratio. Dividends and common share buybacks are actual annual cash payments from the cash flow statement, shown as positive cash outflows; payments to noncontrolling interests and share-compensation withholding taxes are excluded. Zero requires document evidence. Buybacks appear only if at least one reviewed payment exists in the fifteen-year window. The window is fifteen years; years without a single value are omitted. All listed years stay open; CFI, CFF and buybacks for Russia and Kazakhstan appear under More details.
Snapshot reviewed: . Updated after annual filings and three checks against issuer documents. Unreviewed and interim periods are excluded from the annual series.
More: latest reported period
9 months ended 2026-09-30 · $M
| Line | This period | Year ago | Δ |
|---|---|---|---|
| Operating cash flowcash the business generated | 25,087 | 18,589 | +6,498 |
| · incl. stock-based comp (non-cash)share-based compensation | 843 | 795 | |
| Capexpurchases of property & equipment | −2,421 | −2,674 | +253 |
| Free cash flow ≈operating cash flow − capex | 22,666 | 15,915 | +6,751 |
| Investing activities, netcapex, acquisitions, securities | −8,818 | −6,074 | −2,744 |
| · incl. acquisitionsbusinesses net of cash acquired | −1,538 | −4,436 | +2,898 |
| Financing activities, netdebt, buybacks, dividends | −15,033 | −10,613 | −4,420 |
| · incl. buybacksrepurchases of common stock | −5,031 | −5,545 | +514 |
| · incl. dividends paid | −6,170 | −5,914 | −256 |
| FX effect on cash | −11 | 25 | −36 |
| Net change in cash | 1,480 | 1,898 | −418 |
Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.
Shareholders’ equity at Sep 30, 2026: $104B (33% of total assets). Compare with other S&P 500 companies →
Corporate governance
2/2good
- Mar 202610-K FY2025: the annual dividend rate was raised in June 2025 to $8.84 from $8.40; a single class of common stock. sec.gov ↗
- Feb 2026Shares outstanding of 907.7M vs. 945.3M in January 2021 (−4%). data.sec.gov ↗
How it's scored
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
Scoring: 2.0, no deductions: the options-backdating episodes (the $895M suit and the SEC case, 2008) are older than 15 years and not counted; the 2024–2025 suits are unresolved
- Share classes
- Single class of common stock (NYSE: UNH).
- Dilution
- Shares 945.3M (January 2021) → 907.7M (February 2026), −4%; SBC 0.2% of revenue.
- Disclosure
- Full 10-K/10-Q reporting.
- Dividends
- The annual dividend rate was raised in June 2025 to $8.84 from $8.40; buybacks of $5–9B a year in 2021–2025; no cuts.
- Lawsuits & regulators
- Options backdating: the CalPERS suit ($895M) and the SEC case (both 2008) are older than 15 years and not counted. The 2024–2025 shareholder suits and DOJ Medicare probes are unresolved — no deduction.
- Related parties
- 2026 proxy: employment of relatives of directors/executives on the market pay scale, a lease of company-owned real estate to CFO W. DeVeydt at a market rate set by an independent broker ($25K/month), payments to BlackRock/Vanguard for services — immaterial.
How the score works · checked as of Oct 2026
Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · S&P 500 companies that paid dividends 10 years without a gap
UnitedHealth Group (UNH) earnings: FAQ
How does UnitedHealth Group make money?
UnitedHealth Group brought in $113 billion of revenue in Q3 2026, down 0.4% year over year. The largest source was Premiums: $87.1 billion, or 77% of the total, followed by Products ($14.3B, 13%) and Services ($10.2B, 9%); other lines add the remaining 1%. Net income for the quarter was $4.11 billion, up 75.0% year over year.
When is UNH's next earnings date?
We have not yet seen an announcement of the date from UnitedHealth Group (UNH). Based on last year's report on Jan 27, 2026, the next report is expected around Jan 26, 2027.
What time does UNH report earnings?
UnitedHealth Group usually reports before market open: its latest results release was filed with the SEC at 6:14 am ET on Oct 13, 2026.
When did UNH last report earnings?
UnitedHealth Group reported Q3 2026 results on Oct 13, 2026.
Where can I find UnitedHealth Group's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to UNH's filings; this page breaks the latest report down in a Sankey chart.
What was UNH's net income in Q3 2026?
UnitedHealth Group reported net income of $4,110M for Q3 2026 (+75.0% year over year), under US GAAP.
Does UnitedHealth Group pay dividends?
Yes. In 2025, UnitedHealth Group paid $7,916M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has UnitedHealth Group's revenue changed since 2011?
Per its 10-K filings, revenue grew 4.4x: $101,862M in 2011 and $447,567M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
Get it every Monday: who reports this week
Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.
More reports: VEEV · Q2 FY2027 · VRTX · Q3 2026 · VTRS · Q2 2026 · WAT · Q3 2026 · WST · Q3 2026 · ZBH · Q3 2026 · ZTS · Q3 2026 · A · Q3 FY2026 · ABBV · Q3 2026 · ABT · Q3 2026 · all reports